Apricitabine Does Not Select Additional Drug Resistance Mutations in Tissue Culture in Human Immunodeficiency Virus Type 1 Variants Containing K65R, M184V, or M184V plus Thymidine Analogue Mutations

Human immunodeficiency virus type 1 containing the reverse transcriptase mutation M184V or K65R or mutations M41L, M184V, and T215Y did not accumulate additional resistance mutations in the reverse transcriptase when increasing amounts of apricitabine drug pressure were applied. The original mutatio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Oliveira, Maureen, Moisi, Daniela, Spira, Bonnie, Cox, Susan, Brenner, Bluma G., Wainberg, Mark A.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology (ASM) 2009
Assuntos:
Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2663123/
https://ncbi.nlm.nih.gov/pubmed/19223637
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01168-08
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados